Working… Menu

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01520350
Recruitment Status : Terminated (recruitment issues)
First Posted : January 27, 2012
Last Update Posted : July 29, 2014
Bristol-Myers Squibb
Information provided by (Responsible Party):
Serge Beaulieu, Douglas Mental Health University Institute

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2013
Actual Study Completion Date : June 2013